Ocular toxoplasmosis in a patient treated with ustekinumab for psoriasis

Click here for the corresponding questions to this CME article.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental dermatology 2020-08, Vol.45 (6), p.802-804
Hauptverfasser:	Javadzadeh, S., Gkini, M. A., Panos, G. D., Adewoyin, T., Bewley, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotic Prophylaxis - methods Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Chorioretinitis - diagnosis Chorioretinitis - etiology Dermatologic Agents - administration & dosage Dermatologic Agents - adverse effects Dermatologic Agents - therapeutic use Dermatology Female Fundus Oculi Humans Immunotherapy Injections, Subcutaneous Life Sciences & Biomedicine Middle Aged Monoclonal antibodies Psoriasis Psoriasis - drug therapy Recurrence Science & Technology Tomography, Optical Coherence - methods Toxoplasma - isolation & purification Toxoplasmosis Toxoplasmosis, Ocular - diagnosis Toxoplasmosis, Ocular - drug therapy Toxoplasmosis, Ocular - etiology Ustekinumab - administration & dosage Ustekinumab - adverse effects Ustekinumab - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Click here for the corresponding questions to this CME article.
ISSN:	0307-6938 1365-2230
DOI:	10.1111/ced.14198